Idera Pharmaceuticals, Inc.
IDRA · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $12 | $27 | $24 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $4 | $2 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $1 | $1 |
| Total Curr. Assets | $6 | $18 | $30 | $26 |
| Property Plant & Equip (Net) | $0 | $1 | $1 | $1 |
| Goodwill | $5 | $11 | $10 | $0 |
| Intangibles | $67 | $72 | $63 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $73 | $83 | $74 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $78 | $101 | $104 | $26 |
| Liabilities | – | – | – | – |
| Payables | $3 | $5 | $7 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $16 | $12 | $4 |
| Total Curr. Liab. | $18 | $21 | $19 | $5 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $3 | $3 | $4 | $0 |
| Other NC Liab. | $35 | $37 | $59 | $0 |
| Total NC Liab. | $38 | $41 | $64 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $56 | $62 | $83 | $5 |
| Equity | – | – | – | – |
| Pref Stock | $35 | $0 | $20 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$781 | -$759 | -$748 | -$745 |
| AOCI | -$0 | $0 | $0 | $0 |
| Other Equity | $768 | $771 | $748 | $766 |
| Total Equity | $23 | $12 | $21 | $21 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $78 | $74 | $104 | $26 |
| Net Debt | -$2 | -$11 | -$26 | -$24 |